Gilead Sciences, Inc. is a
biopharmaceutical company that discovers, develops and commercializes innovative medicines for patients living with life-threatening diseases. Gilead trusts a significant part of its pre-clinical research in liver diseases to BLB, this partnership enhances Gilead’s ability to develop new treatments for aCLD as efficiently as possible.
Gilead